| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/09/2006 | WO2006025583A1 External preparation of s/o type |
| 03/09/2006 | WO2006025411A1 Liposome improving intracellular drug delivery |
| 03/09/2006 | WO2006025247A1 Mitochondria activators |
| 03/09/2006 | WO2006024953A2 Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 03/09/2006 | WO2005120459A3 Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same |
| 03/09/2006 | WO2005117992A3 Controlled delivery of therapeutic compounds |
| 03/09/2006 | WO2005115418A9 New hydroxapatite calcium phosphates, their method of preparation and their applications |
| 03/09/2006 | WO2005110363A3 Systems and methods for preparation of pharmaceutical dosage using compositions containing aqueous vesicles |
| 03/09/2006 | WO2005040228A3 Disintegratable films for diagnostic devices |
| 03/09/2006 | US20060052532 Swellable, easily cross-linked, essentially linear polymers, and the use of the same in solid phase synthesis |
| 03/09/2006 | US20060052460 Latent reactive blood compatible agents |
| 03/09/2006 | US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor |
| 03/09/2006 | US20060052342 Aldonic acid esters, methods for producing the same, and methods for producing pharmaceutical active ingredients coupled to polysaccharides or polysaccharide derivatives on free amino groups |
| 03/09/2006 | US20060052340 Ophthalmic solution |
| 03/09/2006 | US20060052336 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 03/09/2006 | US20060052323 Method to inhibit cell growth using oligonucleotides |
| 03/09/2006 | US20060052298 Use of stable glutamine derivatives to improve drug absorption |
| 03/09/2006 | US20060052291 Chemically-modified progenipoietin conjugates |
| 03/09/2006 | US20060052288 Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor |
| 03/09/2006 | US20060051425 Method of microencapsulation |
| 03/09/2006 | US20060051423 Chitosan-based transport system |
| 03/09/2006 | US20060051408 Microcapsules for stabilization of cosmetic, pharmaceutical or food products |
| 03/09/2006 | US20060051372 Antigenic compounds |
| 03/09/2006 | US20060051359 Recombinant immunotoxin and use in treating tumors |
| 03/09/2006 | US20060051356 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 03/09/2006 | US20060051355 Methods and means for the treatment of immune-related diseases |
| 03/09/2006 | US20060051349 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 03/09/2006 | US20060051315 Polymers for delivering peptides and small molecules in vivo |
| 03/09/2006 | US20060051296 Thickened beverages for dysphagia |
| 03/09/2006 | US20060049269 Generation of therapeutic microfoam |
| 03/09/2006 | DE4116123B4 Mittel zur Behandlung von Hauterkrankungen Agents for the treatment of skin diseases |
| 03/09/2006 | DE10253623B4 Bioabbaubare kolloidale Partikel, insbesondere für pulmonale Applikationen Biodegradable colloidal particles, in particular for pulmonary applications |
| 03/09/2006 | CA2620919A1 Perorally administrable antimicrobial composition |
| 03/09/2006 | CA2578921A1 Intracellular drug delivery improving liposome |
| 03/09/2006 | CA2578784A1 Compositions containing alpha-2-adrenergic agonist components |
| 03/09/2006 | CA2578746A1 Chemical compounds |
| 03/09/2006 | CA2578347A1 Mitochondria activators |
| 03/09/2006 | CA2577999A1 Glycerol branched polyethylene glycol human growth hormone conjugates, process for their preparation, and methods of use thereof |
| 03/09/2006 | CA2577963A1 Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle |
| 03/09/2006 | CA2577702A1 New polymorphic form of inulin and uses thereof |
| 03/09/2006 | CA2577451A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b and other therapeutic proteins |
| 03/09/2006 | CA2577268A1 Neuroprotective effect of solubilized udca in focal ischemic model |
| 03/09/2006 | CA2575675A1 Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin |
| 03/08/2006 | EP1632561A1 Protein-containing granules and granule formulations |
| 03/08/2006 | EP1632503A1 Ultrasound-assisted synthesis of cyclodextrin-based nanosponges |
| 03/08/2006 | EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 03/08/2006 | EP1632259A2 Anti-angiogene compositions and methods of use |
| 03/08/2006 | EP1632239A1 Pharmaceutical composition comprising a Pseudomonas lindbergii supernatant and a Bacillus coagulans supernatant and its use |
| 03/08/2006 | EP1632237A2 Compositions comprising drospirenone and a complex between ethinyl-estradiol and a cyclodextrin |
| 03/08/2006 | EP1632231A2 Skin penetration enhancing components |
| 03/08/2006 | EP1632224A1 Spill resistant pharmaceutical compositions |
| 03/08/2006 | EP1632137A1 Compositions and processes for water-dispersible phytosterols and phytostanols |
| 03/08/2006 | EP1631545A2 Reagents for modifying biopharmaceuticals, the use and production thereof |
| 03/08/2006 | EP1631331A1 A bioabsorbable delivery system |
| 03/08/2006 | EP1631318A2 Magnetic nanoparticles linked to a ligand |
| 03/08/2006 | EP1631308A2 Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
| 03/08/2006 | EP1631305A2 Sincalide formulations |
| 03/08/2006 | EP1631301A1 Combination chemotherapy comprising 5-fluorouracil or a derivative thereof and a liposomal platinum complex |
| 03/08/2006 | EP1631300A2 High molecular weight polymers, devices and method for making and using same |
| 03/08/2006 | EP1631299A2 Methods and compositions to treat myocardial conditions |
| 03/08/2006 | EP1631278A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex |
| 03/08/2006 | EP1631275A1 Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen |
| 03/08/2006 | EP1631265A2 Use of various agents for inhibiting fibrous adhesions |
| 03/08/2006 | EP1631257A2 Ophthalmic compositions containing a synergistic combination of two polymers |
| 03/08/2006 | EP1631254A1 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| 03/08/2006 | EP1534342B1 Modified saccharides, conjugates thereof, and their manufacture |
| 03/08/2006 | EP1472290A4 Cyclodextrin grafted biocompatible amphiphilic polymer and methods of preparation and use thereof |
| 03/08/2006 | EP1365761B1 Therapeutic combination of amlodipine and benazepril |
| 03/08/2006 | EP1347756B1 Controlled release of anti-arrhythmic agents from a biodegradable hydrogel for local application to the heart |
| 03/08/2006 | EP1347747B1 Method for preparing submicron particle suspensions of pharmaceutical agents |
| 03/08/2006 | EP1347743B1 Composition for treatment of inflammatory disorders |
| 03/08/2006 | EP1326589B1 Nanoparticles |
| 03/08/2006 | EP1326585B1 Method for producing powdery formulations |
| 03/08/2006 | EP1299090B1 Oral pharmaceutical composition with controlled release and prolonged absorption |
| 03/08/2006 | EP1286658B1 Gamma-ifn liquid-droplet aerosol and method |
| 03/08/2006 | EP1280559B1 Acylated cyclodextrin guest inclusion complexes |
| 03/08/2006 | EP1263422B1 Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) |
| 03/08/2006 | EP1230338B1 Continuous-flow method for preparing microparticles |
| 03/08/2006 | EP1220611B1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 03/08/2006 | EP1210068B1 Use of simple amino acids to form porous particles |
| 03/08/2006 | EP1204744B1 Isolated peptide of the horny layer and use thereof |
| 03/08/2006 | EP1123396B1 Minimal promoters and uses thereof |
| 03/08/2006 | EP1094889B1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
| 03/08/2006 | EP1094888B1 Flowable preparations of the water-in-oil emulsion type having an increased water content |
| 03/08/2006 | EP1087781B1 Dietary supplement for supporting cerebrovascular tone |
| 03/08/2006 | EP1073422B1 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 03/08/2006 | EP1041995B1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 03/08/2006 | EP0983038B1 Novel powder compositions |
| 03/08/2006 | EP0771190B1 Lock and key micelles |
| 03/08/2006 | EP0596049B1 Defoaming composition |
| 03/08/2006 | CN1745103A Antibody molecules having specificity for human IL-1 beta |
| 03/08/2006 | CN1744954A Biological control of nanoparticles |
| 03/08/2006 | CN1744918A Polymeric reagents comprising a ketone or a related functional group |
| 03/08/2006 | CN1744917A Sustained-release pharmaceutical composition for lung administration |
| 03/08/2006 | CN1744913A Use of the cathelicidin LL-37 and derivatives thereof for wound healing |
| 03/08/2006 | CN1744912A Stabilized preparation containing protein |
| 03/08/2006 | CN1744904A Ifosfamide compositions for parenteral administration and a process for their preparation |
| 03/08/2006 | CN1744886A Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 03/08/2006 | CN1744885A 薄型含水敷剂 Thin aqueous poultice |
| 03/08/2006 | CN1744884A Solid preparation for dialysis and process for producing the same |